Introduction
============

Next-generation sequencing (NGS) technology has launched a new era of enormous potential and applications in genomic and transcriptomic analyses \[[@r1]-[@r3]\]. With continued cost reductions and improved analytical methods, NGS has begun to have a direct impact on biomedical discovery and clinical outcome \[[@r4]-[@r6]\]. NGS has enabled "meta-genomic" studies to survey the genomes of organisms in a particular ecosystem \[[@r7]\], and decode the entire genomes of species ranging from bacteria \[[@r8],[@r9]\] and viruses \[[@r10]\] to humans \[[@r11]\]. Whole-genome sequencing has made it possible to investigate genetic variations \[[@r12]\], global DNA methylation \[[@r13]\], and in vivo analysis of targets of DNA-binding proteins \[[@r14],[@r15]\]. Deep sequencing of RNA with NGS (called "RNA-seq") allows a comprehensive evaluation and quantification of all subtypes of RNA molecules expressed in a cell or tissue \[[@r16]\]. RNA-seq technology can detect transcripts expressed at low levels \[[@r17]\] and permit the identification of unannotated transcripts and new spliced isoforms \[[@r16],[@r18]\]. The issues related to cross-hybridization and detection levels that limit the accuracy of gene expression estimates by microarray technology are not relevant to the data obtained with RNA-seq \[[@r19]\]. Visualization of mapped sequence reads spanning the splice junctions can also reveal novel splice forms of annotated genes in the mouse retina, which was not possible with earlier hybridization-based technologies. With a steady reduction in the costs of NGS, RNA-seq is now emerging as a method of choice for comprehensive transcriptome profiling.

The vertebrate retina exhibits a highly organized laminar structure that captures, integrates, and transmits visual information to the brain for further processing. Photoreceptors constitute more than 70% of the retinal cells and convert light into electrical signals \[[@r20]\]. Rod photoreceptors mediate dim light vision and can detect a single photon of light, while cone photoreceptors are responsible for daylight vision, color perception, and visual acuity \[[@r21],[@r22]\]. Impairment of photoreceptor function leads to retinal degeneration with a more common pattern of rod death preceding the death of cones \[[@r23]-[@r25]\]. The neural retina leucine zipper (*Nrl*) gene encodes a basic-motif leucine zipper transcription factor necessary for determining rod photoreceptor cell fate and functional maintenance \[[@r26]\]. The *Nrl^−/−^* mouse, generated by creating a loss of function mutation in *Nrl*, has a cone-only retina that serves as a useful model for studies of cone biology \[[@r26]-[@r28]\].

Several previous investigations have elucidated the gene expression landscape specific to whole retina or retinal cell types and during development or aging. Serial analysis of gene expression \[[@r29]-[@r31]\] and cDNA eye gene arrays \[[@r32]-[@r36]\] were initially used to determine signatures of retinal gene expression. Oligonucleotide microarrays have since allowed a more comprehensive approach to expression profiling \[[@r37]-[@r41]\]. Microarray analyses of flow-sorted photoreceptors and single cells from dissociated retinas \[[@r42]-[@r44]\] have begun to reveal new insights into regulatory networks. Application of NGS technology greatly expands the power of expression profiling by identifying all transcripts and spliced isoforms in the tissue or cell type of interest.

Here, we have used the power of NGS-based RNA-seq analysis to investigate in depth the transcriptome of wild-type (WT) and *Nrl^−/−^* retinas and identified a set of differentially expressed genes and spliced isoforms. We have also taken advantage of the knowledge about *Nrl^−/−^* mice to optimize workflows for data analysis and compared our results with those obtained with microarray methods and quantitative reverse transcription polymerase chain reaction (qRT--PCR) analysis. Our studies illustrate that RNA-seq offers a more complete, accurate, and relatively faster approach for comparative and comprehensive analysis of retinal transcriptomes and for discovering novel transcribed sequences. Our validated data analysis workflow should also be beneficial for similar studies by other investigators. Raw data and workflow are available on the [N-NRL/NEI website](http://www.nei.nih.gov/intramural/brooks_molvis_2011.asp).

Methods
=======

Animals and tissue collection
-----------------------------

All investigations on mice were approved by the Animal Care and Use Committee of the National Eye Institute and followed the tenets of the Declaration of Helsinki. C57Bl/6J (referred to as wild type, WT) and *Nrl^−/−^* (on C57Bl/6J background \[[@r26]\]) mice were euthanized with CO~2~ inhalation. The retinas were excised rapidly, frozen on dry ice, and stored at −80 °C.

RNA isolation
-------------

Fresh frozen mouse retinas were lysed with a mortar and pestle in TRIzol Reagent, and total RNA was isolated according to the manufacturer's protocol (Invitrogen, Carlsbad, CA). RNA quality and quantity were assessed with the RNA 6000 Nano Kit (Agilent, Santa Clara, CA).

NGS library construction
------------------------

Whole retinal RNA samples were independently processed from three wild-type and three *Nrl^−/−^* mice at P21. Total RNA (1 μg) was used with the TruSeq mRNA-seq Sample Preparation Kit (Illumina, San Diego, CA) to construct cDNA libraries. The quality of the libraries was verified using the DNA-1000 Kit (Agilent) and quantitation performed with qRT--PCR using ABI 7900HT (Life Technologies, Carlsbad, CA), as suggested in the Sequencing Library qRT--PCR Quantification Guide (Illumina). Gene Expression Master Mix (Life Technologies) was used for the qRT--PCR reactions, and a titration of phiX control libraries was employed as the quantification standard.

Illumina sequencing
-------------------

Each cDNA library (10 pM) was independently loaded into one flow cell lane, and single-read cluster generation proceeded using the TruSeq SR Cluster Generation Kit v5 (Illumina). Sequencing-by-synthesis (SBS) of 70-nucleotide length was performed on a Genome Analyzer IIx running SCS2.8 software using SBS v4 reagents (Illumina). Base calling and chastity filtering were performed using RTA (real-time analysis with SCS2.8).

Burrows--Wheeler transform-based short read aligner analysis workflow
---------------------------------------------------------------------

Burrows--Wheeler Transform Aligner (BWA) \[[@r45]\] was used to align RNA-seq reads against the mouse reference genome (build mm9), downloaded and indexed from the University of California Santa Cruz ([UCSC](http://hgdownload.cse.ucsc.edu/downloads.html)) genome browser database \[[@r46]\]. The resulting sequence alignment/map files were imported into [Partek Genomics Suite](http://www.partek.com/citations?q=cite_partek) (Partek Inc., St. Louis, MO) to compute raw and fragments per kilobase of exon model per million mapped (FPKM) reads normalized expression values of the transcript isoforms defined in the UCSC refFlat file. A stringent filtering criterion of FPKM value 1.0 (equivalent to one transcript per cell \[[@r16]\]) in at least one out of six samples was used to obtain expressed transcripts. The FPKM values of the filtered transcripts were log-transformed using log2 (FPKM+offset) with an offset=1.0. ANOVA (ANOVA) was then performed on the log-transformed data of the two groups (WT and *Nrl^−/−^*) to generate fold change and p values for each transcript. Y-chromosome transcripts were filtered out along with non-coding (nc) RNAs, mitochondrial DNA coded genes, pseudogenes, and predicted protein-coding genes. Differentially expressed mRNA isoforms were filtered for a fold change cutoff of 1.5 and p-value cutoff of 0.05. These criteria were implemented to enable a comparison with previous expression studies. Hierarchical clustering was performed using [Cluster 3.0 software](http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm) \[[@r47]\]. We used uncentered correlation as the distance metric. Heatmaps and dendrograms were generated using [JavaTreeView software](http://jtreeview.sourceforge.net/) \[[@r48]\]. Aligned reads were visualized using the Integrated Genomics Viewer ([IGV](http://www.broadinstitute.org/igv/)) \[[@r49]\].

TopHat/Cufflinks-based analysis workflow
----------------------------------------

Raw reads that passed the chastity filter threshold were mapped using [TopHat](http://tophat.cbcb.umd.edu/) \[[@r50]\] to identify known and novel splice junctions and to generate read alignments for each sample. Genomic annotations were obtained from [Ensembl](http://www.ensembl.org/Mus_musculus/Info/Index) in gene transfer format (GTF). Splice junctions from the six samples were combined into a master junctions file that was used as an input file for the second iteration of TopHat mapping. The transcript isoform level and gene level counts were calculated and FPKM normalized using [Cufflinks](http://cufflinks.cbcb.umd.edu/). An FPKM filtering cutoff of 1.0 in at least one of the six samples was used to determine expressed transcripts. Differential transcript expression was then computed using [Cuffdiff](http://cufflinks.cbcb.umd.edu/manual.html). The resulting lists of differentially expressed isoforms were filtered and sorted into the following categories: protein coding mRNA transcripts and ncRNA transcripts.

qRT--PCR analysis
-----------------

Reverse transcription (RT) reactions were performed using oligo(dT)20 with SuperScript II reagents (Life Technologies) according to the manufacturer's protocol. cDNA synthesized from 2 μg of total RNA (1 μg for minus RT controls) was diluted to 100 μl (fivefold dilution), and from this 1 μl was used for each qRT--PCR reaction. The qRT--PCR reactions were performed in triplicate for TaqMan assays or in duplicate for the SYBR assays, using three biologic replicates per genotype, on a 7900HT Genetic Analyzer (Life Technologies). TaqMan assays were performed using TaqMan Gene Expression Master Mix and TaqMan Gene Expression Assays (Life Technologies) for genes listed in [Table 1](#t1){ref-type="table"}. The SYBR Green assays ([Table 2](#t2){ref-type="table"}) were performed using Power SYBR Green Master Mix (Life Technologies) and oligonucleotides at a final concentration of 200 nM. Oligonucleotides were designed using the [Primer3](http://frodo.wi.mit.edu/primer3/) PCR Primer Design Tool \[[@r51]\] and synthesized by Integrated DNA Technologies (Coralville, IA). To eliminate complications due to contaminating genomic DNA in the RNA samples, qRT--PCR reactions were also performed with minus-RT control, using hypoxanthine guanine phosphoribosyl transferase (*Hprt*) primer pairs that can differentiate between mRNA and genomic DNA (data not shown). Differential expression analysis was performed using the ddCt method \[[@r52]\], with the geometric average of actin, beta (*ActB*) and *Hprt* as the endogenous controls \[[@r53]\].

###### TaqMan assays employed for qRT--PCR validation

  **TaqMan assay ID**   **Gene symbol**   **Gene name**
  --------------------- ----------------- -----------------------------------------------------
  Mm00607939_s1         Actb              actin, b
  Mm00504628_m1         Arr3              arrestin 3, retinal
  Mm00437764_m1         B2m               b-2 microglobulin
  Mm00474799_m1         Cadm3             cell adhesion molecule 3
  Mm00432322_m1         Casp7             caspase 7
  Mm00833234_m1         Cnga1             cyclic nucleotide gated channel a 1
  Mm00489232_m1         Cngb3             cyclic nucleotide gated channel b 3
  Mm00656724_m1         Egr1              early growth response 1
  Mm00442411_m1         Esrrb             estrogen related receptor, b
  Mm00438796_m1         Eya1              eyes absent 1 homolog (Drosophila)
  Mm00445225_m1         Fabp7             fatty acid binding protein 7, brain
  Mm99999915_g1         Gapdh             glyceraldehyde-3-phosphate dehydrogenase
  Mm00492388_g1         Gnat1             guanine nucleotide binding protein, a transducing 1
  Mm00492394_m1         Gnat2             guanine nucleotide binding protein, a transducing 2
  Mm01197698_m1         Gusb              glucuronidase, b
  Mm01318747_g1         Hprt1             hypoxanthine guanine phosphoribosyl transferase 1
  Mm00833431_g1         Hsp90ab1          heat shock protein 90 kDa a, class B member 1
  Mm01340839_m1         Mef2c             myocyte enhancer factor 2C
  Mm00443299_m1         Nr2e3             nuclear receptor subfamily 2, group E, member 3
  Mm00476550_m1         Nrl               neural retina leucine zipper gene
  Mm00524018_m1         Nxnl1             nucleoredoxin-like 1
  Mm00433560_m1         Opn1mw            opsin 1 (cone pigments), medium-wave-sensitive
  Mm00432058_m1         Opn1sw            opsin 1 (cone pigments), short-wave-sensitive
  Mm00476679_m1         Pde6b             phosphodiesterase 6B, cGMP, rod receptor, b
  Mm00473920_m1         Pde6c             phosphodiesterase 6C, cGMP specific, cone, a prime
  Mm01225301_m1         Pgk1              phosphoglycerate kinase 1
  Mm00519814_m1         Reep6             receptor accessory protein 6
  Mm00520345_m1         Rho               Rhodopsin
  Mm00524993_m1         Rorb              RAR-related orphan receptor b
  Mm01612986_gH         Rpl13a            ribosomal protein L13A
  Mm02601831_g1         Rps26             ribosomal protein S26
  Mm00774693_g1         Sall3             sal-like 3 (Drosophila)
  Mm01249143_g1         Socs3             suppressor of cytokine signaling 3
  Mm01277045_m1         Tbp               TATA box binding protein
  Mm00726185_s1         Tubb4             tubulin, b 4
  Mm01198158_m1         Ubc               ubiquitin C
  Mm00457574_m1         Wisp1             WNT1 inducible signaling pathway protein 1

###### SYBR Green assays employed for qRT--PCR validation

  **Gene symbol**       **Gene name**                                                                       **Forward**              **Reverse**
  --------------------- ----------------------------------------------------------------------------------- ------------------------ -----------------------
  Abca13 (Exon 53/55)   ATP-binding cassette, sub-family A (ABC1), member 13                                GACCTTCTGAGATGGCCAAG     TTAACTCCAAGGAGCCCAAA
  Abca13 (Exon 58/60)   ATP-binding cassette, sub-family A (ABC1), member 13                                CGGTACCTCTGGCAAACAAT     GGAAATGGAGCTTCAAGCAG
  Acoxl                 acyl-CoA oxidase-like                                                               TGCTGTATGGAACGAAGCTG     TGTGGAATGTTGAAGGCAGA
  Akt3                  thymoma viral proto-oncogene 3                                                      CATCTGAAACAGACACCCGATA   GTCCGCTTGCAGAGTAGGAG
  Cadm3                 cell adhesion molecule 3                                                            AGGGATTGTGGCTTTCATTG     CTAGGGGCTCAGGAGTTGTG
  Ccdc24                coiled-coil domain containing 24                                                    TGTCACATGTTGCAGAACGA     TCTAAGGCTGGGAATGGATG
  Cd8a                  CD8 antigen, alpha chain                                                            GACATCTCAGCCCCAGAGAC     GCTTGCCTTCCTGTCTGACT
  Cox5b                 cytochrome c oxidase, subunit Vb                                                    CGTCCATCAGCAACAAGAGA     ATAACACAGGGGCTCAGTGG
  Ctss                  cathepsin S                                                                         TAAAGGGCCTGTCTCTGTGG     GCCATCCGAATGTATCCTTG
  Drd4                  dopamine receptor D4                                                                AGACTGCCCACCTCCCTTAC     AAGAAAGGCGTCCAACACAC
  Dynlt3                dynein light chain Tctex-type 3                                                     TTGATGGAGTTTTGGGTGGT     GGTACGGTTCTCCCATCTGA
  Hr                    hairless                                                                            GCCCTCTCTGCTCAGCTCTA     CGGACCACACCGTCTAAGTT
  Klf9                  Kruppel-like factor 9                                                               ACAGTGGCTGTGGGAAAGTC     CATGCTTGGTGAGATGGTCA
  Klhl3                 kelch-like 3                                                                        GAGCACTGGGAGGAGCTATG     AGGAGGTTGGTCTGCTGAGA
  Klhl33                kelch-like 33                                                                       AGCTTCTTCCCTTTGGTGGT     CTACAGCCACCGCTGACATA
  Neurod1               neurogenic differentiation 1                                                        GCGTTGCCTTAGCACTTCTT     AGGAGTGTGTGTTGGCATTT
  Nipal1                NIPA-like domain containing 1                                                       CCCACAAGAGGGAGAAGTCA     GTAAACAGGCTTCCGTTCCA
  Pip5k1a               phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha                             GGGGAACACAGAGCACAAGT     GGTCTTCTGAGGCTCACTGC
  Plekhf2               pleckstrin homology domain containing, family F (with FYVE domain) member 2         GTTGTCGGGTTCGACTGGA      TGCGTCTAGTATTCGCCTCAC
  Rab18                 RAB18, member RAS oncogene family                                                   TGCACGCAAGCATTCTATGT     GGCTCTCTTCCCTGTGTGAC
  Rgs22                 regulator of G-protein signaling 22                                                 GCCCAGAAGATCCTTGAACA     CGCCTTGTCCTCTTCTGTGT
  Rpgrip1               retinitis pigmentosa GTPase regulator interacting protein 1                         GCCATGCTACATGCTCAAGA     TTTGGATGGCCTGGTTTCTA
  Sema7a                sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A   TCTACAGCTCCCAACGATCA     GCTCACAGCTCTGTTCCACA
  Txnip                 thioredoxin interacting protein                                                     TATGTACGCCCCTGAGTTCC     GTTCCCCGCTGTAGAGACTG
  Wisp1                 WNT1 inducible signaling pathway protein 1                                          GCTCTACCACCTGTGGCCTA     ACAGCCTGCGAGAGTGAAGT
  Wscd2                 WSC domain containing 2                                                             TCTGCATCAAGACCCATGAA     ACGGTCTTGCCAAACTTGAG

Results
=======

Sequencing run summary
----------------------

Six libraries of P21 retinal cDNA (three each from WT and *Nrl^−/−^*) were sequenced to obtain 35 to 49 million raw sequence reads per sample ([Table 3](#t3){ref-type="table"}). Of these, 75.8% to 82.7% reads passed the RTA chastity filter and were used for subsequent Burrows--Wheeler Aligner (BWA) and [TopHat](http://tophat.cbcb.umd.edu/) analysis workflows ([Figure 1](#f1){ref-type="fig"}). Due to [TopHat](http://tophat.cbcb.umd.edu/) workflow's power to map across splice junctions, the workflow consistently yielded 6 to 7 million more alignments per sample when compared to BWA.

###### Summary of Illumina base calling and alignments

  **Genotype**        **WT**       **WT**       **WT**       **Nrl^−/−^**   **Nrl^−/−^**   **Nrl^−/−^**
  ------------------- ------------ ------------ ------------ -------------- -------------- --------------
  Total reads         35,872,080   41,785,800   49,076,400   46,689,240     48,480,240     48,656,040
  PF Reads            29,603,280   33,251,160   37,642,800   36,472,800     37,119,960     36,823,320
                      82.7%        79.7%        76.9%        78.2%          76.7%          75.8%
  BWA alignments      24,992,271   27,922,997   32,085,799   30,960,565     31,374,578     31,257,335
  TopHat alignments   30,769,939   34,177,120   39,222,596   38,289,469     38,744,790     38,593,533

Each of the 3 week old WT and *Nrl^−/−^* retina sample was sequenced on a separate lane of the Illumina GAIIx flow cell to obtain 35 to 49 million raw reads. Over 75% of the raw reads passed Illumina's read chastity threshold to yield 29 to 37 million usable PF reads. TopHat mapping always gave significantly more alignments than BWA because of its ability to map across the splice junctions. A relatively smaller numbers of reads and alignments for WT samples 1 and 2 are not a matter of concern as FPKM normalization was used to assess the transcript isoform expression. WT=wild type. PF=pass filter

![Flowchart of RNA-seq data analysis methodology using Burrows-Wheeler Aligner (BWA) and TopHat. Schematic representation of two RNA-seq data analysis workflows and resulting views of the data generated. **A**: BWA workflow: Gapped alignments are performed using the BWA algorithm against the mouse reference genome build mm9, and estimation of the expression of genes at the transcript isoform level is performed by importing aligned reads into the Partek Genomics Suite using annotations provided by the University of California Santa Cruz ([UCSC](http://hgdownload.cse.ucsc.edu/downloads.html)) refflat.txt file. Transcripts expressed at low levels in all samples (\<1 fragments per kilobase of exon model per million mapped reads \[FPKM\]) are filtered out. Differential expression analysis was performed by applying the ANOVA (ANOVA) method, and the resulting list was sorted and filtered into different transcript groups. Clustering of rod and cone enriched genes was performed using Cluster 3.0 software (see Methods). **B**: TopHat workflow: Splice junction mapping was performed using the TopHat algorithm in two phases. In the first phase, splice junctions were detected de novo from the reads from each sample and combined to obtain a master splice junctions list. In the second phase of TopHat alignment, reads from each sample were re-aligned by providing the master junctions list as input. The two-phase mapping approach significantly increased the number of alignments spanning the splice junctions. Estimation of gene expression and differential expression were computed using Cufflinks, Cuffcompare, and Cuffdiff. Sorting and filtering of transcript isoforms were performed as in the BWA workflow.](mv-v17-3034-f1){#f1}

BWA workflow
------------

Based on the BWA analysis workflow, 16,014 transcripts were detected with a normalized FPKM value greater than 1.0 in any of the six samples. Transcripts were filtered based on whether they were mRNAs or ncRNAs. Of the 15,142 mRNA transcripts, only 1,422 met our criteria of differential expression of having a fold change greater than 1.5 and a p-value less than 0.05 ([Table 4](#t4){ref-type="table"}). Of the 1,422 differentially expressed mRNA transcripts (DETs) representing 1,218 unique genes, 551 were downregulated in *Nrl^−/−^* (including rod-specific genes) retinas, and 871 were upregulated in *Nrl^−/−^* (including cone-enriched genes and those involved in retinal remodeling) retinas.

###### Summary of transcript isoforms detected by BWA/ANOVA and TopHat/Cufflinks workflows

  **Analysis**                 **BWA/ANOVA**   **TopHat/Cufflinks**
  ---------------------------- --------------- ----------------------
  Total detected transcripts   16,014          34,115
  mRNA                         15,142          32,001
  mRNA DETs                    1,422           3,258

The BWA workflow employed refflat.txt annotation for mouse build mm9 from UCSC genome browser. The TopHat workflow employed GTF annotation for mouse build mm9 from the Ensembl database. After FPKM filtering (see Materials and Methods), transcribed features were classified as protein coding mRNAs and non-coding (nc) RNAs. The features classified as protein-coding mRNAs were further filtered based on fold change (≥1.5) and p-value (\<0.05) to be considered significantly differentially expressed transcripts (DETs).

TopHat workflow
---------------

A total of 34,115 transcripts were detected with a normalized FPKM value of greater than 1.0 in any of the samples in either group. Transcripts were filtered based on whether they were protein-coding mRNAs or ncRNAs. Of the 32,001 mRNA transcripts, only 3,258 met our criteria of differential expression ([Table 4](#t4){ref-type="table"}). The DETs represented 1990 unique genes; 1,504 were downregulated in *Nrl^−/−^* (including rod-specific genes) retinas, and 1,754 were upregulated in the *Nrl^−/−^* (including cone-enriched genes and those involved in retinal remodeling) retinas.

Comparison of the results from BWA and TopHat analyses
------------------------------------------------------

The BWA/ANOVA and TopHat/Cufflinks analyses were compared to assess the consistency and quality of the results. Using the official [Mouse Genome Informatics](http://www.informatics.jax.org/) gene symbol as the linking term, Venn diagrams were constructed to summarize the overlap between the set of all ([Figure 2A](#f2){ref-type="fig"}), the top 500 ([Figure 2B](#f2){ref-type="fig"}), and the top 200 ([Figure 2C](#f2){ref-type="fig"}) DETs from the BWA workflow and the DET list from the TopHat workflow. A comparison of the full list of BWA DETs to the TopHat list revealed only 51.7% overlap between the differentially expressed genes (DEGs) from BWA and TopHat. This overlap increased to 73.8% and 87.8% when only the top 500 and 200 DEGs from BWA, respectively, were considered. Subsequent analyses were performed using BWA data.

![Venn diagrams comparing differentially expressed transcripts (DETs) between the *Nrl^−/−^* and WT groups from BWA and TopHat analyses. Despite major differences in the UCSC refFlat annotations used by Burrows-Wheeler Aligner (BWA) and Ensembl annotations used by TopHat, most of the genes identified by BWA were also identified as significant by TopHat. **A**: Comparison of the total number of DETs identified as significant (fold change ≥1.5 and p-value \<0.05) by the two methods. **B**: Inclusion of the top 500 DETs (424 unique genes) identified as significant by BWA and in the full TopHat DET list. **C**: Inclusion of the top 200 DETs (179 unique genes) identified as significant by BWA and in the full TopHat DET list. We assess the two methods based on a comparison of qRT--PCR data for the genes detected by either or both methods. The discrepancy between the results can be attributed to differences in the input annotation files used (UCSC refFlat versus Ensembl GTF) by the two methods and their alignment algorithms.](mv-v17-3034-f2){#f2}

Regression analysis of quantitative expression values obtained with RNA-seq and TaqMan qRT--PCR assays
------------------------------------------------------------------------------------------------------

We first assessed the correlation between the FPKM values (obtained with RNA-seq) with their corresponding qRT--PCR crossing threshold (Ct) values from the TaqMan assays; the two values represent the quantitative levels of expression of a specific transcript in the RNA sample. For this purpose, we chose 24 differentially expressed genes (DEGs, reflecting a wide range of expression) and 12 housekeeping genes (HKGs). The Ct values from three biologic replicates (without normalization) were then compared to the corresponding log2 FPKM values ([Figure 3](#f3){ref-type="fig"}). A least-squares regression analysis of DEGs provided an R^2^ value of 0.8798, with a corresponding slope of −1.056, suggesting a strong inverse relationship between Ct and log2 FPKM values over a dynamic range of 4--5 orders of magnitude. Only one out of 24 genes, cell adhesion molecule 3 (*Cadm3*), fell outside this correlation. Further investigation of the RNA-seq aligned reads showed that our qRT--PCR assay was specific for only one of the two retina-expressed spliced isoforms of *Cadm3*. The reanalysis using a SYBR assay designed to detect both *Cadm3* transcripts confirmed the linear correlation between RNA-seq and qRT--PCR analysis. Interestingly, FPKM and Ct values for 6 of the 12 HKGs did not show the expected linear relationship; these included ubiquitin C (*Ubc*), *ActB*, ribosomal protein L13A (*Rpl13a*), ribosomal protein S26 (*Rps26*), phosphoglycerate kinase 1 (*Pgkl*), and most severely glyceraldehyde-3-phosphate dehydrogenase (*Gapdh*). With the exception of *Ubc* that was underestimated by qRT--PCR (in the same manner as *Cadm3*), the BWA workflow underestimated all others.

![Correlation of RNA-seq and qRT--PCR. The correlations between the RNA-seq fragments per kilobase of exon model per million mapped reads (FPKM) values and the corresponding qRT--PCR crossing threshold (Ct) values are shown. FPKM values represented in log~2~ scale, and non-normalized Ct values are an average of three biologic replicates. Data generated from differentially expressed genes (black) is contrasted with data generated from the housekeeping genes (red). The dashed line, associated equation, and goodness of fit value were generated by least-squares regression analysis of the differentially expressed data set. Since a lower Ct value indicates an increased initial amount of target mRNA, an inverse relationship between FPKM and Ct values is expected if a correlation exists.](mv-v17-3034-f3){#f3}

A comparison of RNA-seq and qRT--PCR data for housekeeping genes
----------------------------------------------------------------

RNA-seq data were evaluated for the expression of 27 established HKGs ([Table 5](#t5){ref-type="table"}) included in the control qRT--PCR plates from the following vendors: Life Technologies (Mouse Endogenous Control Array), SA Biosciences, Frederick, MD (Mouse Housekeeping Genes RT^2^ Profiler PCR Array), and Qiagen, Valencia, CA (QuantiTect Housekeeping Genes). Comparison of qRT--PCR data for 12 genes (that were tested) showed almost complete concordance of expression with the RNA-seq results. Only one gene, *Ubc*, revealed a significant difference in expression between the WT and *Nrl^−/−^* retinas with qRT--PCR (−1.89 fold) compared to the RNA-seq (−1.19 fold) analyses. *Gapdh* showed a relatively high change in expression in qRT--PCR and RNA-seq (−1.49 and −1.37 fold, respectively). *Hprt* and *Rpl13a* revealed lower variation in qRT--PCR and RNA-seq, respectively. *Actb*, TATA box binding protein (*Tbp*), glucuronidase, beta (*Gusb*), and *Pgk1* were among the best HKGs for qRT--PCR and RNA-seq normalization. For further qRT--PCR analyses, we employed *ActB* and *Hprt* in all normalization calculations.

###### Quantitative expression profiles of housekeeping genes obtained by qRT--PCR and RNA-seq

  **Transcript**                                                     **Gene ID**        **Description**                                                                        **WT FPKM**   **Nrl^−/−^ FPKM**   **RNA-seq FC**   **WT Ct**   **Nrl^−/−^ Ct**   **qPCR FC**
  ------------------------------------------------------------------ ------------------ -------------------------------------------------------------------------------------- ------------- ------------------- ---------------- ----------- ----------------- -------------
  [NM_007393](http://www.ncbi.nlm.nih.gov/nuccore/NM_007393)         Actb               Actin, b                                                                               136.24        128                 −1.07            19.61       19.84             −1.17
  [NM_020559](http://www.ncbi.nlm.nih.gov/nuccore/NM_020559)         Alas1              Aminolevulinic acid synthase 1                                                         8.06          8.46                1.05                                            
  [NM_009735](http://www.ncbi.nlm.nih.gov/nuccore/NM_009735)         B2m                β 2-microglobulin                                                                      **11.88**     **20.11**           **1.71**         **25.67**   **25.09**         **1.5**
  [NM_019468](http://www.ncbi.nlm.nih.gov/nuccore/NM_019468)         G6pd2              Glucose-6-phosphate dehydrogenase 2                                                    9.85          12.13               1.23                                            
  [NM_008084](http://www.ncbi.nlm.nih.gov/nuccore/NM_008084)         Gapdh              Glyceraldehyde-3-phosphate dehydrogenase                                               **6.68**      **4.47**            **−1.49**        **17.64**   **18.09**         **−1.37**
  [NM_010368](http://www.ncbi.nlm.nih.gov/nuccore/NM_010368)         Gusb               b-glucuronidase                                                                        3.63          4                   1.1              28.72       28.67             1.03
  [NM_008194](http://www.ncbi.nlm.nih.gov/nuccore/NM_008194)         Gyk                Glycerol kinase                                                                        2.62          2.69                1.02                                            
  [NM_001110251](http://www.ncbi.nlm.nih.gov/nuccore/NM_001110251)   Hmbs (isoform 2)   Hydroxymethylbilane synthase                                                           3.16          3.25                1.03                                            
  [NM_013551](http://www.ncbi.nlm.nih.gov/nuccore/NM_013551)         Hmbs (isoform 1)   Hydroxymethylbilane synthase                                                           1.89          2.1                 1.11                                            
  [NM_013556](http://www.ncbi.nlm.nih.gov/nuccore/NM_013556)         Hprt               Hypoxanthine guanine phosphoribosyl transferase                                        47.5          65.34               1.37             22.61       22.58             1.02
  [NM_008302](http://www.ncbi.nlm.nih.gov/nuccore/NM_008302)         Hsp90ab1           Heat shock protein 90 kDa α class B member 1                                           149.09        199.47              1.33             22.51       22.25             1.2
  [NM_001081113](http://www.ncbi.nlm.nih.gov/nuccore/NM_001081113)   Ipo8               Importin 8                                                                             10.48         11.31               1.08                                            
  [NM_023144](http://www.ncbi.nlm.nih.gov/nuccore/NM_023144)         Nono               Non-POU-domain-containing octamer-binding                                              28.64         38.59               1.35                                            
  [NM_008828](http://www.ncbi.nlm.nih.gov/nuccore/NM_008828)         Pgk1               Phosphoglycerate kinase 1                                                              17.88         16.91               −1.06            20.86       21.05             −1.15
  [NM_009089](http://www.ncbi.nlm.nih.gov/nuccore/NM_009089)         Polr2a             Polymerase (RNA) II (DNA directed) polypeptide A                                       50.56         36.5                −1.39                                           
  [NM_008907](http://www.ncbi.nlm.nih.gov/nuccore/NM_008907)         Ppia               Peptidylprolyl isomerase A (cyclophilin A)                                             2.38          2.68                1.13                                            
  [NM_009438](http://www.ncbi.nlm.nih.gov/nuccore/NM_009438)         Rpl13a             Ribosomal protein L13A                                                                 45.25         44.63               −1.01            20.22       20.62             −1.32
  [NM_007475](http://www.ncbi.nlm.nih.gov/nuccore/NM_007475)         Rplp0              Ribosomal protein large P0                                                             39.12         39.67               1.02                                            
  [NM_026020](http://www.ncbi.nlm.nih.gov/nuccore/NM_026020)         Rplp2              Ribosomal protein large P2                                                             18.51         17.15               −1.07                                           
  [NM_013765](http://www.ncbi.nlm.nih.gov/nuccore/NM_013765)         Rps26              Ribosomal protein S26                                                                  22.94         21.71               −1.06            21.7        21.94             −1.19
  [NM_023281](http://www.ncbi.nlm.nih.gov/nuccore/NM_023281)         Sdha               Succinate dehydrogenase complex subunit A, flavoprotein                                74.03         80.45               1.09                                            
  [NM_013684](http://www.ncbi.nlm.nih.gov/nuccore/NM_013684)         Tbp                TATA box binding protein                                                               18.51         18.9                1.02             25          25.24             −1.18
  [NM_011638](http://www.ncbi.nlm.nih.gov/nuccore/NM_011638)         Tfrc               Transferrin receptor                                                                   34.3          37.53               1.09                                            
  [NM_011654](http://www.ncbi.nlm.nih.gov/nuccore/NM_011654)         Tuba2              Tubulin, α 2                                                                           37.53         46.85               1.25                                            
  [NM_009451](http://www.ncbi.nlm.nih.gov/nuccore/NM_009451)         Tubb4              Tubulin β 4                                                                            79.34         80.45               1.01             23.13       23.45             −1.25
  [NM_019639](http://www.ncbi.nlm.nih.gov/nuccore/NM_019639)         Ubc                Ubiquitin C                                                                            **33.13**     **27.86**           **−1.19**        **28.29**   **29.21**         **−1.89**
  [NM_011740](http://www.ncbi.nlm.nih.gov/nuccore/NM_011740)         Ywhaz              Tyrosine 3-monooxygenase-tryptophan 5-monooxygenase activation protein z polypeptide   38.05         51.98               1.37                                            

We evaluated housekeeping genes (HKGs) for their expression in RNA-seq data and by qRT--PCR analysis. Rows in bold indicate genes that are significantly differentially expressed and hence not good choices for HKGs. WT=wild type, Ct=crossing threshold, FPKM=fragments per kilobase of exon model per million mapped reads.

A comparison of RNA-seq and qRT--PCR analysis for DEGs
------------------------------------------------------

Based on the RNA-seq data from the WT and *Nrl^−/−^* retinas, we selected 25 DEGs (12 downregulated and 13 upregulated) showing a wide range of differential expression for validation with qRT--PCR analysis. qRT--PCR data for all genes validated the RNA-seq results ([Figure 4](#f4){ref-type="fig"}). The WNT1 inducible signaling pathway protein 1 (*Wisp1*) TaqMan assay did not produce an amplicon in any of the experiments performed; subsequent examination of the RNA-seq data revealed that this assay did not correspond to the splice variant expressed in the retina. Additional analysis using a SYBR assay with oligonucleotides specific to the retinal splice variant confirmed the differential expression of *Wisp1* (−43.9 fold change) in the *Nrl^−/−^* retina compared to the WT.

![qRT--PCR validation of RNA-seq results. Comparison of differential expression values determined by RNA-seq (dark gray) and qRT--PCR (light gray) for 25 differentially expressed genes identified by Burrows-Wheeler Aligner (BWA) workflow. Error bars represent the standard error of the mean. Neural retina leucine zipper gene (*Nrl*) was not detectable by qRT--PCR and therefore are left blank in the graph. Note that Rhodopsin (*Rho*), guanine nucleotide binding protein, alpha transducing 1 (*Gnat1*), cyclic nucleotide gated channel alpha 1 (*Cnga1*), and nuclear receptor subfamily 2, group E, member 3 (*Nr2e3*) having average crossing threshold (Ct) values greater than 30 in the *Nrl^−/−^* samples are considered extremely low to non-expressing.](mv-v17-3034-f4){#f4}

Expression levels of transcripts in the WT and *Nrl^−/−^* retina
----------------------------------------------------------------

The preceding analysis clearly demonstrates the high reliability and accuracy of the data obtained with RNA-seq methodology. We therefore used RNA-seq data to derive absolute expression levels of individual transcripts. The top 25 genes highly expressed in the WT or *Nrl^−/−^* retina are listed in [Table 6](#t6){ref-type="table"} and [Table 7](#t7){ref-type="table"}. As predicted, most of these genes encode proteins involved in photoreceptor function/metabolism.

###### Top 25 highly expressed transcripts in wild-type retina based on RNA-seq data.

  **Transcript ID**                                                  **Gene ID**           **Gene name**                                                             **WT FPKM**   ***Nrl^−/−^* FPKM**
  ------------------------------------------------------------------ --------------------- ------------------------------------------------------------------------- ------------- ---------------------
  [NM_145383](http://www.ncbi.nlm.nih.gov/nuccore/NM_145383)         *Rho*                 Rhodopsin                                                                 8135.4        1.7
  [NM_008140](http://www.ncbi.nlm.nih.gov/nuccore/NM_008140)         *Gnat1*               Guanine nucleotide binding protein γ transducing activity polypeptide 1   4011.7        2
  [NM_008938](http://www.ncbi.nlm.nih.gov/nuccore/NM_008938)         ***Prph2***           Peripherin 2                                                              1448.2        367.1
  [NM_012065](http://www.ncbi.nlm.nih.gov/nuccore/NM_012065)         ***Pde6g***           Phosphodiesterase 6G cGMP-specific rod γ                                  1269.5        552.6
  [NM_009073](http://www.ncbi.nlm.nih.gov/nuccore/NM_009073)         *Rom1*                Retinal outer segment membrane protein 1                                  948.8         229.1
  [NM_015745](http://www.ncbi.nlm.nih.gov/nuccore/NM_015745)         ***Rbp3***            Retinol binding protein 3                                                 885.3         1024
  [NM_009118](http://www.ncbi.nlm.nih.gov/nuccore/NM_009118)         ***Sag***             S-antigen retina and pineal gland                                         765.4         548.7
  [NM_011676](http://www.ncbi.nlm.nih.gov/nuccore/NM_011676)         ***Unc119***          Unc-119 homolog                                                           719.1         407.3
  [NM_024458](http://www.ncbi.nlm.nih.gov/nuccore/NM_024458)         *Pdc*                 Phosducin                                                                 689.8         302.3
  [NM_009038](http://www.ncbi.nlm.nih.gov/nuccore/NM_009038)         *Rcvrn*               Recoverin                                                                 643.6         288
  [NM_011099](http://www.ncbi.nlm.nih.gov/nuccore/NM_011099)         ***Pkm2***            Pyruvate kinase muscle                                                    604.7         467.9
  [NM_001159730](http://www.ncbi.nlm.nih.gov/nuccore/NM_001159730)   *Pdc*                 Phosducin                                                                 580           250.7
  [NM_146079](http://www.ncbi.nlm.nih.gov/nuccore/NM_146079)         *Guca1b*              Guanylate cyclase activator 1B                                            552.6         68.1
  [NM_008131](http://www.ncbi.nlm.nih.gov/nuccore/NM_008131)         ***Glul***            Glutamate-ammonia ligase                                                  545           530.1
  [NM_001136074](http://www.ncbi.nlm.nih.gov/nuccore/NM_001136074)   *Nrl*                 Neural retina leucine zipper                                              545           1.9
  [NM_001160017](http://www.ncbi.nlm.nih.gov/nuccore/NM_001160017)   *Gnb1*                Guanine nucleotide binding protein β polypeptide 1                        487.8         24.4
  [NM_011428](http://www.ncbi.nlm.nih.gov/nuccore/NM_011428)         ***Snap25***          Synaptosomal-associated protein 25 kDa                                    471.1         576
  [NM_146086](http://www.ncbi.nlm.nih.gov/nuccore/NM_146086)         *Pde6a*               Rod photoreceptor cGMP phosphodiesterase a subunit                        433.5         35.8
  [NM_026358](http://www.ncbi.nlm.nih.gov/nuccore/NM_026358)         ***4930583H14Rik***   Unknown                                                                   407.3         362
  [NM_013415](http://www.ncbi.nlm.nih.gov/nuccore/NM_013415)         ***Atp1b2***          ATPase Na^+^K+ transporting β 2 polypeptide                               369.6         608.9
  [NM_144921](http://www.ncbi.nlm.nih.gov/nuccore/NM_144921)         *Atp1a3*              Α 3 subunit of Na^+^K+ ATPase                                             367.1         286
  [NM_008806](http://www.ncbi.nlm.nih.gov/nuccore/NM_008806)         *Pde6b*               Phosphodiesterase 6B cGMP-specific rod β                                  364.6         16.2
  [NM_001160016](http://www.ncbi.nlm.nih.gov/nuccore/NM_001160016)   *Gnb1*                Guanine nucleotide binding protein β polypeptide 1                        352.1         18.1
                                                                     *(isoform 2)*                                                                                                  
  [NM_008142](http://www.ncbi.nlm.nih.gov/nuccore/NM_008142)         *Gnb1*                Guanine nucleotide binding protein β polypeptide 1                        349.7         17.9
                                                                     *(isoform 1)*                                                                                                  
  [NM_010314](http://www.ncbi.nlm.nih.gov/nuccore/NM_010314)         *Gngt1*               Guanine nucleotide binding protein g transducing activity polypeptide 1   340.1         203.7

As photoreceptors constitute almost 70% of cells in P21 WT and *Nrl^−/−^* retina, the high expressed genes (in bold) likely encode proteins associated with general photoreceptor function/metabolism. WT=wild type

###### Top 25 highly expressed transcripts in *Nrl−/−* retina based on RNA-seq data.

  **Transcript ID**                                                  **Gene ID**           **Gene name**                                                             **WT FPKM**   **Nrl^−/−^ FPKM**
  ------------------------------------------------------------------ --------------------- ------------------------------------------------------------------------- ------------- -------------------
  [NM_007538](http://www.ncbi.nlm.nih.gov/nuccore/NM_007538)         *Opn1sw*              Opsin 1 short-wave-sensitive                                              149.1         2740.1
  [NM_015745](http://www.ncbi.nlm.nih.gov/nuccore/NM_015745)         ***Rbp3***            Retinol binding protein 3                                                 885.3         1024
  [NM_008141](http://www.ncbi.nlm.nih.gov/nuccore/NM_008141)         *Gnat2*               Guanine nucleotide binding protein a transducing 2                        70.5          861.1
  [NM_013530](http://www.ncbi.nlm.nih.gov/nuccore/NM_013530)         *Gnb3*                Guanine nucleotide binding protein β polypeptide 3                        103.3         786.9
  [NM_133205](http://www.ncbi.nlm.nih.gov/nuccore/NM_133205)         *Arr3*                Arrestin 3, retinal                                                       69.6          652.6
  [NM_023898](http://www.ncbi.nlm.nih.gov/nuccore/NM_023898)         *Pde6h*               Phosphodiesterase 6H cGMP-specific cone g                                 91.1          634.7
  [NM_013415](http://www.ncbi.nlm.nih.gov/nuccore/NM_013415)         ***Atp1b2***          ATPase Na^+^K+ transporting β 2 polypeptide                               369.6         608.9
  [NM_011428](http://www.ncbi.nlm.nih.gov/nuccore/NM_011428)         ***Snap25***          Synaptosomal-associated protein 25 kDa                                    471.1         576
  [NM_012065](http://www.ncbi.nlm.nih.gov/nuccore/NM_012065)         ***Pde6g***           Phosphodiesterase 6G cGMP-specific rod g                                  1269.5        552.6
  [NM_009118](http://www.ncbi.nlm.nih.gov/nuccore/NM_009118)         ***Sag***             S-antigen retina and pineal gland                                         765.4         548.7
  [NM_008131](http://www.ncbi.nlm.nih.gov/nuccore/NM_008131)         ***Glul***            Glutamate-ammonia ligase                                                  545           530.1
  [NM_053245](http://www.ncbi.nlm.nih.gov/nuccore/NM_053245)         *Aipl1*               Aryl hydrocarbon receptor interacting protein-like 1                      313           515.6
  [NM_009305](http://www.ncbi.nlm.nih.gov/nuccore/NM_009305)         *Syp*                 Synaptophysin                                                             326.3         505
  [NM_008189](http://www.ncbi.nlm.nih.gov/nuccore/NM_008189)         *Guca1a*              Guanylate cyclase activator 1A (retina)                                   306.6         487.8
  [NM_011099](http://www.ncbi.nlm.nih.gov/nuccore/NM_011099)         ***Pkm2***            Pyruvate kinase muscle                                                    604.7         467.9
  [NM_013494](http://www.ncbi.nlm.nih.gov/nuccore/NM_013494)         *Cpe*                 Carboxypeptidase E                                                        337.8         439.6
  [NM_023121](http://www.ncbi.nlm.nih.gov/nuccore/NM_023121)         *Gngt2*               Guanine nucleotide binding protein g transducing activity polypeptide 2   32            407.3
  [NM_011676](http://www.ncbi.nlm.nih.gov/nuccore/NM_011676)         ***Unc119***          Unc-119 homolog                                                           719.1         407.3
  [NM_021273](http://www.ncbi.nlm.nih.gov/nuccore/NM_021273)         *Ckb*                 Creatine kinase brain                                                     290           398.9
  [NM_007450](http://www.ncbi.nlm.nih.gov/nuccore/NM_007450)         *Slc25a4*             Solute carrier family 25 member 4                                         313           385.3
  [NM_008938](http://www.ncbi.nlm.nih.gov/nuccore/NM_008938)         ***Prph2***           Peripherin 2                                                              1448.2        367.1
  [NM_026358](http://www.ncbi.nlm.nih.gov/nuccore/NM_026358)         ***4930583H14Rik***   Unknown                                                                   407.3         362
  [NM_016774](http://www.ncbi.nlm.nih.gov/nuccore/NM_016774)         *Atp5b*               ATP synthase H^+^ transporting mitochondrial F1 complex β polypeptide     315.2         352.1
  [NM_001038664](http://www.ncbi.nlm.nih.gov/nuccore/NM_001038664)   *Gngt2*               Guanine nucleotide binding protein γ transducing activity polypeptide 2   22.6          337.8
  [NM_010106](http://www.ncbi.nlm.nih.gov/nuccore/NM_010106)         *Eef1a1*              Eukaryotic translation elongation factor 1 α 1                            265           328.6

As photoreceptors constitute almost 70% of cells in P21 WT and *Nrl^−/−^* retina, the high expressed genes (in bold) likely encode proteins associated with general photoreceptor function/metabolism. WT=wild type

Rod and cone photoreceptor enriched genes
-----------------------------------------

We then focused on DEGs between the *Nrl^−/−^* and WT retinas. A total of 1,422 transcripts, corresponding to 1,218 unique genes, showed a minimum fold change of 1.5 at p≤0.05. Hierarchical clustering of all differentially expressed transcripts resulted in two distinct clusters: one cluster of 477 genes downregulated in the *Nrl^−/−^* retina includes all known rod-specific genes such as rhodopsin (*Rho*; FC=-4,804), guanine nucleotide binding protein, alpha transducing 1 (*Gnat1*; FC=-2,034), and nuclear receptor subfamily 2, group E, member 3 (*Nr2e3*; FC=-227.5; [Figure 5A](#f5){ref-type="fig"} and [Table 8](#t8){ref-type="table"}); and the other cluster of 741 upregulated genes had all cone-specific genes such as opsin 1, short-wave-sensitive (*Opn1sw*; FC=18.4), cyclic nucleotide gated channel beta 3 (*Cngb3*; FC=18.1), and *Gnat2* (FC=12.2; [Figure 5B](#f5){ref-type="fig"} and [Table 9](#t9){ref-type="table"}).

![Heatmaps and hierarchical clusters of differentially expressed rod-specific genes and cone-specific genes or those involved in retinal remodeling. Heatmaps with dendrograms of clusters of differentially expressed rod genes (**A**) and cone / retinal remodeling genes (**B**) by applying hierarchical clustering. A filtered list of mRNA transcript isoforms was further revised for fold change ≥1.5 and p-value \<0.05, and duplicate gene symbol rows were deleted to retain the most expressed isoform as reflective of the gene. This list was used to generate the heatmap and the master cluster. Specific clusters of rod specific genes and cone-specific or retinal remodeling genes were identified as clusters containing known rod genes (e.g., Rhodopsin \[*Rho*\], guanine nucleotide binding protein, alpha transducing 1 \[*Gnat1*\], cyclic nucleotide gated channel alpha 1 \[*Cnga1*\], and nuclear receptor subfamily 2, group E, member 3 \[*Nr2e3*\]) and cone genes (e.g., fatty acid binding protein 7, brain \[*Fabp7*\], cyclic nucleotide gated channel alpha 3 \[*Cnga3*\], cyclic nucleotide gated channel beta 3 \[*Cngb3*\]). Columns 1, 2, and 3 are wild-type samples, and columns 4, 5, and 6 are *Nrl^−/−^* samples.](mv-v17-3034-f5){#f5}

###### Top 25 transcripts down-regulated in *Nrl^−/−^* retina compared to WT.

  **Transcript**                                                     **Gene ID**         **Gene name**                                                              **WT FPKM**   **Nrl^−/−^ FPKM**   **FC**
  ------------------------------------------------------------------ ------------------- -------------------------------------------------------------------------- ------------- ------------------- ----------
  [NM_145383](http://www.ncbi.nlm.nih.gov/nuccore/NM_145383)         Rho                 Rhodopsin                                                                  8135.4        1.7                 −4803.93
  [NM_008140](http://www.ncbi.nlm.nih.gov/nuccore/NM_008140)         Gnat1               Guanine nucleotide binding protein γ transducing activity polypeptide 1    4011.7        2                   −2033.85
  [NM_001136074](http://www.ncbi.nlm.nih.gov/nuccore/NM_001136074)   Nrl                 Neural retina leucine zipper                                               545           1.9                 −284.05
  [NM_007723](http://www.ncbi.nlm.nih.gov/nuccore/NM_007723)         Cnga1               Intracellular cGMP activated cation channel                                232.3         1                   −229.13
  [NM_013708](http://www.ncbi.nlm.nih.gov/nuccore/NM_013708)         Nr2e3               Nuclear receptor subfamily 2 group E member 3                              237.2         1                   −227.54
  [NM_144813](http://www.ncbi.nlm.nih.gov/nuccore/NM_144813)         Slc24a1             Solute carrier family 24 member 1 (sodium-potassium-calcium exchanger 1)   263.2         3.2                 −81.57
  [NM_145963](http://www.ncbi.nlm.nih.gov/nuccore/NM_145963)         Kcnj14              Potassium inwardly-rectifying channel subfamily J member 14                63.6          1.4                 −44.02
  [NM_139292](http://www.ncbi.nlm.nih.gov/nuccore/NM_139292)         Reep6               Receptor accessory protein 6                                               317.4         8.6                 −36.76
  [NM_025491](http://www.ncbi.nlm.nih.gov/nuccore/NM_025491)         Susd3               Sushi domain containing 3                                                  58.1          1.7                 −34.06
  [NM_011934](http://www.ncbi.nlm.nih.gov/nuccore/NM_011934)         Esrrb (isoform 1)   Estrogen-related receptor β                                                67.2          2.6                 −26.17
  [NM_001007576](http://www.ncbi.nlm.nih.gov/nuccore/NM_001007576)   Gucy2f              Guanylate cyclase 2f                                                       36.5          1.6                 −22.78
  [NM_008806](http://www.ncbi.nlm.nih.gov/nuccore/NM_008806)         Pde6b               Phosphodiesterase 6B cGMP-specific rod β                                   364.6         16.2                −22.32
  [NM_001195413](http://www.ncbi.nlm.nih.gov/nuccore/NM_001195413)   Cngb1               Cyclic nucleotide gated channel β 1                                        52.3          2.5                 −21.11
  [NM_001160017](http://www.ncbi.nlm.nih.gov/nuccore/NM_001160017)   Gnb1 (isoform 3)    Guanine nucleotide binding protein β polypeptide 1                         487.8         24.4                −19.97
  [NM_008736](http://www.ncbi.nlm.nih.gov/nuccore/NM_008736)         Nrl                 Neural retina leucine zipper                                               20            1                   −19.97
  [NM_008142](http://www.ncbi.nlm.nih.gov/nuccore/NM_008142)         Gnb1 (isoform 1)    Guanine nucleotide binding protein β polypeptide 1                         349.7         17.9                −19.7
  [NM_007472](http://www.ncbi.nlm.nih.gov/nuccore/NM_007472)         Aqp1                Aquaporin 1                                                                42.5          2.2                 −19.56
  [NM_001160016](http://www.ncbi.nlm.nih.gov/nuccore/NM_001160016)   Gnb1 (isoform 2)    Guanine nucleotide binding protein β polypeptide 1                         352.1         18.1                −19.29
  [NM_153803](http://www.ncbi.nlm.nih.gov/nuccore/NM_153803)         Glb1l2              Galactosidase, β 1-like 2                                                  55.7          3.5                 −16.11
  [NM_001159500](http://www.ncbi.nlm.nih.gov/nuccore/NM_001159500)   Esrrb (isoform 2)   Estrogen-related receptor β                                                22.5          1.5                 −15.03
  [NM_172802](http://www.ncbi.nlm.nih.gov/nuccore/NM_172802)         Fscn2               Fascin homolog 2, actin-bundling protein, retinal                          41.6          3                   −14.03
  [NM_001033498](http://www.ncbi.nlm.nih.gov/nuccore/NM_001033498)   Gramd2              Member of the GRAM domain containing family                                20.3          1.4                 −14.03
  [NM_027001](http://www.ncbi.nlm.nih.gov/nuccore/NM_027001)         2610034M16Rik       Unknown                                                                    69.6          5.1                 −13.64
  [NM_018865](http://www.ncbi.nlm.nih.gov/nuccore/NM_018865)         Wisp1               WNT1 inducible signaling pathway protein                                   17.8          1.4                 −12.21
  [NM_146086](http://www.ncbi.nlm.nih.gov/nuccore/NM_146086)         Pde6a               Rod photoreceptor cGMP phosphodiesterase α subunit                         433.5         35.8                −12.13

Many of the genes down-regulated in *Nrl^−/−^* retina represent rod-specific transcripts, whereas upregulated genes include those associated with cone function and retinal remodeling.

###### Top 25 transcripts upregulated in *Nrl^−/−^* retina compared to WT.

  **Transcript**                                                     **Gene ID**         **Gene title**                                                            **WT FPKM**   **Nrl^−/−^ FPKM**   **FC**
  ------------------------------------------------------------------ ------------------- ------------------------------------------------------------------------- ------------- ------------------- --------
  [NM_021272](http://www.ncbi.nlm.nih.gov/nuccore/NM_021272)         Fabp7               Fatty acid binding protein 7 brain                                        2.5           62.7                24.59
  [NM_007538](http://www.ncbi.nlm.nih.gov/nuccore/NM_007538)         Opn1sw              Opsin 1 short-wave-sensitive                                              149.1         2740.1              18.38
  [NM_013927](http://www.ncbi.nlm.nih.gov/nuccore/NM_013927)         Cngb3               Cyclic nucleotide gated channel β 3                                       4.7           85.6                18.13
  [NM_033614](http://www.ncbi.nlm.nih.gov/nuccore/NM_033614)         Pde6c (isoform 1)   Phosphodiesterase 6C, cGMP-specific, cone, α prime                        12.6          199.5               15.78
  [NM_001170959](http://www.ncbi.nlm.nih.gov/nuccore/NM_001170959)   Pde6c (isoform 2)   Phosphodiesterase 6C, cGMP-specific, cone, α prime                        13.8          207.9               14.93
  [NM_001038664](http://www.ncbi.nlm.nih.gov/nuccore/NM_001038664)   Gngt2 (isoform 2)   Guanine nucleotide binding protein γ transducing activity polypeptide 2   22.6          337.8               14.93
  [NM_001166651](http://www.ncbi.nlm.nih.gov/nuccore/NM_001166651)   Klhl33              Kelch-like 33                                                             3             42.2                14.03
  [NM_007627](http://www.ncbi.nlm.nih.gov/nuccore/NM_007627)         Cckbr               Cholecystokinin B receptor                                                3.6           50.2                13.83
  [NM_017474](http://www.ncbi.nlm.nih.gov/nuccore/NM_017474)         Clca3               Chloride channel calcium activated 3                                      3.4           46.2                13.64
  [NM_027132](http://www.ncbi.nlm.nih.gov/nuccore/NM_027132)         Otop3               Otopetrin 1 homolog                                                       4.4           56.5                12.82
  [NM_023121](http://www.ncbi.nlm.nih.gov/nuccore/NM_023121)         Gngt2 (isoform 1)   Guanine nucleotide binding protein γ transducing activity polypeptide 2   32            407.3               12.73
  [NM_178747](http://www.ncbi.nlm.nih.gov/nuccore/NM_178747)         Gulo                L gulonolactone oxidase                                                   6.5           82.7                12.64
  [NM_008141](http://www.ncbi.nlm.nih.gov/nuccore/NM_008141)         Gnat2               Guanine nucleotide binding protein γ transducing activity polypeptide 2   70.5          861.1               12.21
  [NM_145574](http://www.ncbi.nlm.nih.gov/nuccore/NM_145574)         Ccdc136             Coiled-coil domain containing 136                                         17.6          213.8               12.13
  [NM_009918](http://www.ncbi.nlm.nih.gov/nuccore/NM_009918)         Cnga3               Cyclic nucleotide gated channel α 3                                       5             54.6                11
  [NM_133205](http://www.ncbi.nlm.nih.gov/nuccore/NM_133205)         Arr3                Arrestin 3, retinal                                                       69.6          652.6               9.32
  [NM_184053](http://www.ncbi.nlm.nih.gov/nuccore/NM_184053)         Calu                Calumenin, a calcium ion binding protein                                  14.8          131.6               8.82
  [NM_183224](http://www.ncbi.nlm.nih.gov/nuccore/NM_183224)         Fam19a3             Family with sequence similarity 19, member A3                             30.7          266.9               8.69
  [NM_010164](http://www.ncbi.nlm.nih.gov/nuccore/NM_010164)         Eya1                Eyes absent 1 homolog                                                     1.4           12.6                8.63
  [NM_001201378](http://www.ncbi.nlm.nih.gov/nuccore/NM_001201378)   Ccdc136             Coiled-coil domain containing 136                                         16.6          142                 8.51
  [NM_025659](http://www.ncbi.nlm.nih.gov/nuccore/NM_025659)         Abi3                ABI gene family, member 3                                                 1.4           11.5                8.28
  [NM_013848](http://www.ncbi.nlm.nih.gov/nuccore/NM_013848)         Ermap               Erythroblast membrane-associated protein                                  1.2           9.8                 8
  [NM_133167](http://www.ncbi.nlm.nih.gov/nuccore/NM_133167)         Parvb               Parvin β                                                                  9             71.5                7.94
  [NM_007419](http://www.ncbi.nlm.nih.gov/nuccore/NM_007419)         Adrb1               Β-1 adrenergic receptor                                                   6.5           50.2                7.73
  [NM_138653](http://www.ncbi.nlm.nih.gov/nuccore/NM_138653)         Bspry               B-box and SPRY-domain containing (zetin-1)                                1.4           10.6                7.73

Many of the genes down-regulated in *Nrl^−/−^* retina represent rod-specific transcripts, whereas upregulated genes include those associated with cone function and retinal remodeling.

We then compared our DEG list with two published studies that examined WT and *Nrl^−/−^* retinas: a recent transcript-level RNA-seq analysis that included 6,123 DETs \[[@r54]\] and a gene-level microarray analysis showing 438 DEGs \[[@r38]\] ([Figure 6](#f6){ref-type="fig"}). To obtain the list of DEGs from the Mustafi et al. \[55\] data set, we performed ANOVA on their FPKM data from [GEO database](http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29752). Interestingly, the DEGs lists from the three studies had only 203 common genes including many previously identified genes specifically expressed in cone (fatty acid binding protein 7, brain \[*Fabp7*\], *Opn1sw*, *Cngb3*, and *Gnat2*) or rod (*Rho*, *Gnat1*, cyclic nucleotide gated channel alpha 1 \[*Cnga1*\], and *Nr2e3*) photoreceptors. To assess the power of RNA-seq to more comprehensively identify DETs than microarray, we examined the list of 634 genes identified in common by the RNA-seq studies but not by the microarray study. This list included 18 retinal disease genes (ATP-binding cassette, sub-family A (ABC1), member 4 \[*Abca4*\], cadherin 23 (otocadherin) \[*Cdh23*\], ADP-ribosylation factor-like 6 \[*Arl6*\], Bardet-Biedl syndrome 9 (human) \[*Bbs9*\], calcium binding protein 4 \[*Cabp4*\], cyclic nucleotide gated channel alpha 3 \[*Cnga3*\], G protein-coupled receptor 98 \[*Gpr98*\], guanylate cyclase activator 1a (retina) \[*Guca1a*\], opsin 1 (cone pigments), medium-wave-sensitive (color blindness, deutan) \[*Opn1mw*\], orthodenticle homolog 2 (Drosophila) \[*Otx2*\], phosphodiesterase 6G, cGMP-specific, rod, gamma \[*Pde6g*\], peripherin 2 \[*Prph2*\], retinol binding protein 4, plasma \[*Rbp4*\], retinol dehydrogenase 1 (all trans) \[*Rdh1*\], regulator of G-protein signaling 9 binding protein \[*Rgs9bp*\], unc-119 homolog (C. elegans) \[*Unc119*\], Usher syndrome 2A (autosomal recessive, mild) homolog (human) \[*Ush2a*\], and whirlin \[*Whrn*\]) and several known genes involved in [visual perception](http://www.sph.uth.tmc.edu/retnet/disease.htm) (guanylate cyclase 2e \[*Gucy2e*\], guanylate cyclase 2f \[*Gucy2f*\], recoverin \[*Rcvrn*\], RAR-related orphan receptor beta \[*Rorb*\], and sal-like 3 (Drosophila) \[*Sall3*\]). Several genes showing large differential expression values might participate in rod homeostasis (galactosidase, beta 1-like 2 \[*Glb1l2*\] FC=-14.02, GRAM domain containing 2 \[*Gramd2*\] FC=-14.0, carbohydrate (chondroitin 6/keratan) sulfotransferase 3 \[*Chst3*\] FC=-4.8, desert hedgehog \[*Dhh*\] FC=-4.1, and ADP-ribosylation factor-like 4D \[*Arl4d*\] FC=-3.6) and cone function (dual specificity phosphatase 23 \[*Dusp23*\] FC=6.3, cyclin-dependent kinase 11B \[*Cdkl1*\] FC=6.1, tryptophan hydroxylase 1 \[*Tph1*\] FC=4.7, muscle glycogen phosphorylase \[*Pygm*\] FC=4.6, cyclin-dependent kinase 6 \[*Cdk6*\] FC=4.0, *Sall3* FC=3.9, and early growth response 1 \[*Egr1*\] FC=3.7).

![Comparison of the current and previous data sets of differentially expressed transcripts of *Nrl^−/−^* versus wild type (WT) mouse retina. Overlap between the differentially expressed transcripts (DETs) identified in the current study and previous studies using mouse retinas from the same age and genotype was determined using the Mouse Genome Informatics (MGI) gene symbol as the identifier. The current study includes all mRNA transcripts identified with the Burrows-Wheeler Aligner (BWA) workflow (fold change ≥1.5 and p value \<0.05). The 438 DETs of an Affymetrix microarray study \[[@r38]\] and 6,123 DETs from another RNA-seq study \[[@r54]\] with similar criteria were used for comparison with our study. Of the 438 DETs from the Corbo et al. \[[@r38]\] study, 157 transcripts are not significantly differentially expressed in our data, 11 are expressed below the fragments per kilobase of exon model per million mapped reads (FPKM) detection threshold of 1.0, and 38 do not map to the current annotations. Of the 6,123 DETs from the Mustafi et al. \[[@r54]\] study, 4,858 transcripts are not significantly differentially expressed in our study, 348 are expressed below our FPKM detection threshold of 1.0, and 62 do not map to the current annotations.](mv-v17-3034-f6){#f6}

Our RNA-seq data allowed us to identify 359 genes not identified in previous investigations. To further assess the quality of our analysis, we performed qRT--PCR validation of 15 genes identified by other studies (but not in our study) as differentially expressed and of 7 genes uniquely identified by our study (but not by other studies; [Table 10](#t10){ref-type="table"}). Of the 15 genes identified by other studies, only three (ATP-binding cassette, sub-family A (ABC1), member 13 \[*Abca13*\], CD8 antigen, alpha chain \[*Cd8a*\], and acyl-CoA oxidase-like \[*Acoxl*\]) were confirmed with qRT--PCR as being differentially expressed. We also detected these three as differentially expressed but had filtered them out because of FPKM values that were less than 1.0 in all samples. Interestingly, the *Abca13* transcript detected in the retina had only sequence reads for exons 56 through 62. This finding was supported by qRT--PCR using two SYBR assays designed to exons 53/55 and exons 56/58. All seven genes uniquely identified by our study were validated as significantly differentially expressed.

###### Validation of selected genes from study comparisons by qRT--PCR

  **Name**            **Transcript ID**                                                  **qRT--PCR FC**   **Corbo FC**   **Mustafi FC**   **This report FC**   **p-value**   **WT FPKM**   **Nrl^−/−^ FPKM**
  ------------------- ------------------------------------------------------------------ ----------------- -------------- ---------------- -------------------- ------------- ------------- -------------------
  **Corbo**                                                                                                                                                                                 
  Abca13 exon 53/55   [NM_178259](http://www.ncbi.nlm.nih.gov/nuccore/NM_178259)         NA                −11.58         NA               −4.18                0.000278      0.75          0.18
  Abca13 exon 56/58   [NM_178259](http://www.ncbi.nlm.nih.gov/nuccore/NM_178259)         −21.36            −11.58         NA               −4.18                0.000278      0.75          0.18
  Amz2                [NM_025275](http://www.ncbi.nlm.nih.gov/nuccore/NM_025275)         1.09              −6.77          1.13             1.06                 0.1122        15.06         16.13
  Klf9                [NM_010638](http://www.ncbi.nlm.nih.gov/nuccore/NM_010638)         1.09              −2.6           −1.15            1.11                 0.2481        29.7          33.12
  Pip5k1a             [NM_008847](http://www.ncbi.nlm.nih.gov/nuccore/NM_008847)         1.43              50             1.03             1.35                 0.0015        11.81         16.25
  Sema7a              [NM_011352](http://www.ncbi.nlm.nih.gov/nuccore/NM_011352)         1.03              20             −1.39            1.13                 0.0634        13.33         15.19
  Txnip               [NM_023719](http://www.ncbi.nlm.nih.gov/nuccore/NM_023719)         −1.07             12.5           1                1.04                 0.7347        2.17          2.01
  **Mustafi**                                                                                                                                                                               
  Cox5b               [NM_009942](http://www.ncbi.nlm.nih.gov/nuccore/NM_009942)         1.26              NA             −12.15           1.01                 0.9342        18.31         18.24
  Drd4                [NM_007878](http://www.ncbi.nlm.nih.gov/nuccore/NM_007878)         −1.23             NA             −8.72            −1.92                0.0764        39.6          20.92
  Cd8a                [NM_009857](http://www.ncbi.nlm.nih.gov/nuccore/NM_009857)         11.5              NA             21.17            9.03                 3.47E-06      0.08          0.73
  Ctss                [NM_021281](http://www.ncbi.nlm.nih.gov/nuccore/NM_021281)         1.25              NA             6.92             1.29                 0.0228        3.82          5.23
  **Corbo-Mustafi**                                                                                                                                                                         
  Acoxl               [NM_028765](http://www.ncbi.nlm.nih.gov/nuccore/NM_028765)         −28.6             −13.93         −34              −4.61                0.0291        0.28          0.06
  Rpgrip1             [NM_001168515](http://www.ncbi.nlm.nih.gov/nuccore/NM_001168515)   −1.3              −2.32          −1.83            1.06                 0.1157        29.94         31.85
  Dynlt3              [NM_025975](http://www.ncbi.nlm.nih.gov/nuccore/NM_025975)         1.28              5              3.45             1.46                 0.0036        17.79         26.39
  Rab18               [NM_181070](http://www.ncbi.nlm.nih.gov/nuccore/NM_181070)         1.37              3.23           3.31             1.29                 0.0028        33.71         43.77
  Neurod1             [NM_010894](http://www.ncbi.nlm.nih.gov/nuccore/NM_010894)         1.38              2.63           2.2              1.14                 0.0888        168.51        192.86
  **This report**                                                                                                                                                                           
  Plekhf2             [NM_175175](http://www.ncbi.nlm.nih.gov/nuccore/NM_175175)         −5.88             NA             −1.35            −5.35                0.000428      37.77         7.21
  Klhl3               [NM_001195075](http://www.ncbi.nlm.nih.gov/nuccore/NM_001195075)   −6.9              NA             NA               −3.29                0.000101      8.62          2.6
  Ccdc24              [NM_001034876](http://www.ncbi.nlm.nih.gov/nuccore/NM_001034876)   −2.93             NA             NA               −2.64                0.0031        66.86         24.85
  Rgs22               [NM_001195748](http://www.ncbi.nlm.nih.gov/nuccore/NM_001195748)   11.24             NA             NA               3.84                 5.93E-07      1.95          7.47
  Hr                  [NM_021877](http://www.ncbi.nlm.nih.gov/nuccore/NM_021877)         3.82              NA             1.25             3.89                 0.000307      16.38         63.51
  Wscd2               [NM_177292](http://www.ncbi.nlm.nih.gov/nuccore/NM_177292)         4.1               NA             1.13             4                    0.000123      5.73          22.91
  Klhl33              [NM_001166651](http://www.ncbi.nlm.nih.gov/nuccore/NM_001166651)   27.12             NA             NA               14.03                2.34E-06      3.02          42.25

Differential expression of genes identified in three global profiling studies (Corbo, Mustafi and this report) was validated by qRT--PCR. Genes shown under the Corbo and Mustafi subheadings were identified in respective studies, but not in the current study. Corbo-Mustafi subheading indicates genes identified in both Corbo and Mustafi studies but not in the current report. The two genes, *Cd8a* and *Acoxl,* identified previously were differentially expressed by qRT--PCR but were filtered out of our sequencing data because of the low FPKM values observed. The gene *Abca13* was detected as only expressing the last 7 exons of the annotated sequence. qRT--PCR assays that distinguished between the two isoforms were able to confirm the differential expression of the last 7 *Abca13* exons. This gene was filtered out of our sequencing results because of the low FPKM value observed. All genes included in this report subheading were uniquely identified by the current study (and not in Corbo and Mustafi reports). FC, p-val, and FPKM values in this report are derived from the sequencing results reported here. Genes were selected as having the largest fold changes in each category and from current annotation in the latest mm9 Refseq build. All differentially expressed genes identified in this report could be validated by qRT--PCR. FC=fold change, NA=not applicable, FPKM=fragments per kilobase exon model per million reads.

The significantly lower number of DETs detected by our study compared to the Mustafi et al. study (2011; 1,422 versus 6,123, respectively) can be attributed to the following:

1\. We used a stringent 1.0 FPKM cutoff that generated a list of genes with significant base level expression and fewer false positives than a lower expression level threshold. If we had decreased our threshold to 0.1 FPKM, we would have detected 975 more DETs; however, these genes are expressed at an extremely low level and their impact must be weighed against the increase in false positives. We chose a conservative criterion to identify significant and bona fide differentially expressed genes.

2\. Mustafi et al. \[[@r54]\] pooled multiple RNA samples before generating the library and used the identical library on multiple lanes of the sequencer. Our experimental design consisted of libraries generated from individual biologic replicates that allowed us to eliminate the transcripts based on p-value.

Several DETs we identified might contribute to photoreceptor function but are not yet characterized; these include pleckstrin homology domain containing, family F (with FYVE domain) member 2 (*Plekhf2*; FC=-5.35), kelch-like 13 (Drosophila) \[*Klhl3*\] (FC=-3.3), NIPA-like domain containing 1 (*Nipal1*; FC=-2.8), and coiled-coil domain containing 24 (*Ccdc24*; FC=-2.6) in the WT retina, and kelch-like 33 (Drosophila) \[*Klhl33*\] (FC=14), WSC domain containing 2 (*Wscd2*; FC=4), hairless (*Hr*; FC=3.9) and regulator of G-protein signaling 22 (*Rgs22*; FC=3.8) in the *Nrl^−/−^* retina. We also identified Crx opposite strand transcript 1 (*Crxos1*; FC=4.1), which is exclusively expressed in the eye from the opposite strand of a key retinal transcription factor, cone-rod homeobox containing gene (*Crx*) \[[@r55]\]. An interesting new finding is the retinal expression of multiple genes from the Kelch-like family (Klhl3, 4, 5, 18, 33, 36), solute carrier family (\>30 members), and zinc-finger protein family (\>10 members). Mutations in at least one gene from each family have previously been associated with retinal disease: Klhl7 with autosomal dominant RP \[[@r56]\], Slc24A1 with autosomal-recessive congenital stationary night blindness \[[@r57]\], and Znf513 with autosomal-recessive retinitis pigmentosa (RP) \[[@r58]\].

Discussion
==========

Specific patterns of gene expression define the morphology and function of distinct cell types and tissues. Changes in gene expression are associated with complex biologic processes, including development, aging, and disease pathogenesis. Until recently, such investigations focused on one or a few genes at a time. Advances in genomic technology have permitted simultaneous evaluation of most, if not all, genes that respond to an extrinsic microenvironment or intrinsic biologic program(s). Such studies are critical for delineating gene networks that can be targeted for treating specific diseases. RNA-seq allows comprehensive evaluation of transcriptomes, alternative transcripts, and coding polymorphisms. However, analyzing RNA-seq data has been challenging due to the complexity associated with quality control, sequence alignments, and handling of large data sets \[[@r59]\]. Several algorithms \[[@r45],[@r60]\] have been proposed for mapping sequence reads to the reference genome, and multiple workflows \[[@r16],[@r50]\] suggested for RNA-seq data analysis. Here, we report a detailed RNA-seq methodology using WT and *Nrl^−/−^* retinas as a study paradigm and establish the high performance of NGS technology compared to microarray and qRT--PCR platforms for transcript identification and quantification studies. Consistent with recent studies \[[@r61]\], our RNA-seq data demonstrate high sensitivity, a wider dynamic range of coverage, and lower technical variability.

Quantitative RT--PCR has long been considered the "gold standard" for mRNA quantification \[[@r62],[@r63]\], and hence routinely used to validate results from transcriptome analysis studies. We show that FPKM values from RNA-seq analysis have a strong linear correlation across at least four orders of magnitude with Ct values from qRT--PCR. Expression of several HKGs is underestimated by RNA-seq because of the algorithmic limitation associated with alignment of reads that map to multiple genomic locations (paralogous sequences or pseudogenes). All of the outlying HKGs inspected had a lower-than-projected FPKM value due to varying numbers of associated pseudogenes \[[@r64]-[@r67]\]. For example, *Gapdh* has 331 pseudogenes in the mouse genome \[[@r64]\]. Our qRT--PCR data projected an FPKM value of approximately 4000 for *Gapdh*, yet the BWA workflow estimated an FPKM of only 6.6 in the WT retina (see [Figure 3](#f3){ref-type="fig"}). This was also the case, but less severe, for *Pgk1*, *Rps26*, *Rpl13a*, and *ActB*. Current algorithms proportionally divide the number of reads aligning to multiple genes during FPKM calculation among those genes. In our study, unsuitable qRT--PCR assay design explains the remaining exceptions to the linear correlation between qRT--PCR and RNA-seq. After careful visual inspection of the aligned reads in IGV, we found that the assay designed for *Wisp1* was not specific to the splice variant expressed in the retina. Similarly, the assays designed for *Cadm3* and *Ubc* were specific to one of the two transcripts expressed in the retina. Hence, RNA-seq provides a better assessment of alternate isoforms, and transcript quantification is not limited by the design of qRT--PCR assays.

We took advantage of the RNA-seq data to inspect the expression of commonly used HKGs (see [Table 5](#t5){ref-type="table"}) for normalization in qRT--PCR assays. The choice generally depends on specific tissue and/or developmental time points being investigated. Our RNA-seq studies suggest that most of the HKGs can be used for normalization calculation in qRT--PCR assays; however, *Gapdh*, β-2 microglobulin (*B2m*), and *Ubc* do not appear to be good choices. Additional RNA-seq data would help in delineating relevant HKGs appropriate for qPCR validation in developing retina or cell types.

We compared two different strategies for analyzing WT and *Nrl^−/−^* RNA-seq data. The BWA workflow relies on fast and accurate gapped alignment of reads to the exonic regions of the genome. Since the gap between most adjacent exons is larger than a few bases, the cumulative gap extension penalty underestimates the quality of the alignment of reads spanning the splice junctions. Hence, the BWA workflow produced accurate quantitative estimation of gene and transcript isoform expression while losing valuable information about alternate splicing. The higher accuracy of quantitative gene expression estimates by the BWA workflow compared to those by TopHat is evident from the stronger correlation determined by linear regression analysis of the DETs. The regression line from BWA had a slope of −1.056 (compared to −0.905 for TopHat) and R^2^ of 0.8798 (compared to 0.7727 for TopHat).

The TopHat workflow maps the reads to exonic regions of the reference genome as well as across all known and putative splice junctions defined in the Ensembl GTF file. TopHat attempts to map reads across splice junctions defined in the Ensembl GTF file and across novel splice junctions detected during the first phase of alignment. Hence, the TopHat workflow maps significantly more reads starting with the same number of pass filter (PF) reads and detects additional transcript isoforms missed by the BWA workflow. The source of genomic annotations used by these methods is another important difference. UCSC refFlat annotation (used by the BWA workflow) for the mouse reference genome (build mm9) contained approximately 28,000 unique transcript isoforms, whereas the Ensembl GTF file (used by the TopHat workflow) for the same genome build listed three times more unique transcript isoforms. The problem is amplified because of the lack of one-to-one mapping for several transcripts defined in the UCSC refFlat file in Ensembl GTF. Hence, a non-trivial number of DETs detected by the BWA workflow could not be mapped to any DET from the TopHat workflow (see [Figure 2](#f2){ref-type="fig"}, regions shaded in green).

The BWA workflow detects about 16,000 transcripts in the retina, with a minimum expression equivalent to one transcript per cell (i.e., 1 FPKM) \[[@r16]\]. When the criteria were relaxed to cover transcripts expressed at low levels (0.1 FPKM), 20,707 transcripts were detected in the retina. This is not surprising as the whole retina includes more than 50 distinct neuronal cell types, and each cell would achieve protein diversity largely by alternative promoter usage and/or alternative splicing \[[@r68]\]. The TopHat workflow yields thousands of known and putative transcript isoforms not previously described in the retina. However, validating these novel isoforms predicted from RNA-seq data remains a challenge.

Integrated analysis of RNA-seq data with miRNA-seq, transcription factor binding sites data (chromatin immunoprecipitation sequencing-Chip-Seq), genetic variations (expression Quantitative Trait Loci) \[[@r69]\], and methylation patterns would allow decoding of the complex regulatory networks associated with retinal development and function. Several technical improvements would however be necessary to overcome the bias introduced into the RNA-seq data due to GC content, mappability of reads, length of the gene, and regional differences due to local sequence structure \[[@r70]\]. RNA-seq methods are more likely to identify longer differentially expressed transcripts than shorter transcripts with the same effect size \[[@r71]\]. New statistical methods are being developed to correct for systematic biases inherent in NGS data \[[@r70]-[@r72]\]. In the coming years, we will witness an explosion in high throughput genomic methods that are expected to revolutionize biology and biomedical discovery.
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